The Schnitzler syndrome
2010

Understanding Schnitzler Syndrome

publication 10 minutes Evidence: moderate

Author Information

Author(s): Dan Lipsker

Primary Institution: Clinique Dermatologique, Faculté de Médecine, Université de Strasbourg

Hypothesis

Is Schnitzler syndrome an acquired auto-inflammatory disease?

Conclusion

Schnitzler syndrome is a rare auto-inflammatory condition that can be effectively treated with the IL-1 receptor antagonist anakinra.

Supporting Evidence

  • Schnitzler syndrome shares features with genetically determined auto-inflammatory syndromes.
  • Anakinra provides rapid control of symptoms within hours after the first injection.
  • About 15% to 20% of patients may develop a lymphoproliferative disorder.

Takeaway

Schnitzler syndrome is a rare disease that causes fever and skin rashes, and it can be treated with a special medicine that helps reduce symptoms quickly.

Methodology

This review summarizes clinical and biological features of Schnitzler syndrome and discusses treatment options.

Limitations

The study lacks long-term follow-up data on patients and does not establish a specific biological marker for diagnosis.

Participant Demographics

The syndrome primarily affects adults, with a mean age of onset around 51 years, and there is a slight male predominance.

Digital Object Identifier (DOI)

10.1186/1750-1172-5-38

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication